Company page

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. (ticker: ESPR) is a public company based in the United States with a market capitalization of approximately $811.7 million. The company focuses on developing and commercializing innovative therapies for patients with elevated cholesterol levels. Esperion aims to provide effective treatment options to improve cardiovascular health.